-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$63.80103.7% Upside
Q32 Bio Inc. Frequently Asked Questions
-
What analysts cover Q32 Bio Inc.?
Q32 Bio Inc. has been rated by research analysts at Oppenheimer, Wells Fargo, Leerink Partners, Raymond James, Piper Sandler in the past 90 days.